NCT06320990View on ClinicalTrials.gov

Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection

PHASE1RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 22, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

May 31, 2027

Conditions
Pancreatic CystPancreatic Mucinous Cystic Neoplasm
Interventions
DRUG

Tamoxifen 20mg

Tamoxifen is a nonsteroidal antiestrogen for oral administration.

Trial Locations (1)

68198

RECRUITING

University of Nebraska Medical Center, Omaha

All Listed Sponsors
lead

University of Nebraska

OTHER